X4 Pharmaceuticals annual gross margin
2024
2025
X4 Pharmaceuticals Gross Margin Growth & History (XFOR)
X4 Pharmaceuticals's gross margin was 83.60% for fiscal 2025.
View full X4 Pharmaceuticals company overviewX4 Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 83.60% | +14.77 pp |
| 2024 | 2024-12-31 | 68.83% | — |
X4 Pharmaceuticals quarterly gross margin
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 81.64% | −1.84 pp |
| Q1 2026 | 2026-03-31 | 77.92% | −5.71 pp |
| Q4 2025 | 2025-12-31 | 85.83% | +6.89 pp |
| Q3 2025 | 2025-09-30 | 80.11% | +20.65 pp |
| Q2 2025 | 2025-06-30 | 83.48% | +31.08 pp |
| Q1 2025 | 2025-03-31 | 83.63% | — |
| Q4 2024 | 2024-12-31 | 78.94% | — |
| Q3 2024 | 2024-09-30 | 59.46% | — |
| Q2 2024 | 2024-06-30 | 52.40% | — |
X4 Pharmaceuticals gross margin trends
Between the periods ended 2024-12-31 and 2025-12-31, X4 Pharmaceuticals's gross margin increased from 68.83% to 83.60%, a change of +14.77 percentage points. The latest reported quarter, Q2 2026, shows 81.64%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review X4 Pharmaceuticals source filings ↗